Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	filopodium membrane	MYO10 SYNE2 UTRN	1.66e-05	21	50	3	GO:0031527
GeneOntologyCellularComponent	coated vesicle membrane	GAD1 STON1 HLA-E LRP2 RASSF9	1.60e-04	215	50	5	GO:0030662
GeneOntologyCellularComponent	MHC class I protein complex	HLA-E MR1	2.49e-04	10	50	2	GO:0042612
GeneOntologyCellularComponent	clathrin-coated vesicle membrane	GAD1 STON1 LRP2 RASSF9	4.20e-04	147	50	4	GO:0030665
Domain	Pyridoxal_deC	PDXDC1 GAD1	2.11e-04	8	52	2	PF00282
Domain	DDC_GAD_HDC_YDC	PDXDC1 GAD1	2.11e-04	8	52	2	PS00392
Domain	PyrdxlP-dep_de-COase	PDXDC1 GAD1	2.11e-04	8	52	2	IPR002129
Domain	MHC_I	HLA-E MR1	1.54e-03	21	52	2	PF00129
Domain	MHC_I_a_a1/a2	HLA-E MR1	1.54e-03	21	52	2	IPR001039
Domain	Actinin_actin-bd_CS	SYNE2 UTRN	1.85e-03	23	52	2	IPR001589
Domain	Spectrin	SYNE2 UTRN	1.85e-03	23	52	2	PF00435
Domain	ACTININ_2	SYNE2 UTRN	1.85e-03	23	52	2	PS00020
Domain	ACTININ_1	SYNE2 UTRN	1.85e-03	23	52	2	PS00019
Domain	-	HLA-E MR1	2.02e-03	24	52	2	3.30.500.10
Domain	MHC_I-like_Ag-recog	HLA-E MR1	2.02e-03	24	52	2	IPR011161
Domain	Spectrin_repeat	SYNE2 UTRN	2.94e-03	29	52	2	IPR002017
Domain	Spectrin/alpha-actinin	SYNE2 UTRN	3.57e-03	32	52	2	IPR018159
Domain	SPEC	SYNE2 UTRN	3.57e-03	32	52	2	SM00150
Domain	PTPc	PTPRK PTPN18	4.51e-03	36	52	2	SM00194
Domain	PyrdxlP-dep_Trfase_major_sub2	PDXDC1 GAD1	4.51e-03	36	52	2	IPR015422
Domain	Myosin_head_motor_dom	MYO10 MYO5C	5.01e-03	38	52	2	IPR001609
Domain	MYOSIN_MOTOR	MYO10 MYO5C	5.01e-03	38	52	2	PS51456
Domain	Myosin_head	MYO10 MYO5C	5.01e-03	38	52	2	PF00063
Domain	MYSc	MYO10 MYO5C	5.01e-03	38	52	2	SM00242
Domain	MHC_I/II-like_Ag-recog	HLA-E MR1	5.01e-03	38	52	2	IPR011162
Domain	TYR_PHOSPHATASE_PTP	PTPRK PTPN18	5.27e-03	39	52	2	PS50055
Domain	RA_dom	MYO10 RASSF9	5.54e-03	40	52	2	IPR000159
Domain	PTPase_domain	PTPRK PTPN18	5.82e-03	41	52	2	IPR000242
Domain	Y_phosphatase	PTPRK PTPN18	5.82e-03	41	52	2	PF00102
Domain	PyrdxlP-dep_Trfase	PDXDC1 GAD1	5.82e-03	41	52	2	IPR015424
Domain	PyrdxlP-dep_Trfase_major_sub1	PDXDC1 GAD1	5.82e-03	41	52	2	IPR015421
Domain	Znf_FYVE_PHD	BPTF ING1 RNF34	7.97e-03	147	52	3	IPR011011
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	DENND4A MYOM1 SYNE2 HLA-E PKM ABCF2 NOCT TRIP11 UTRN	4.93e-08	497	52	9	23414517
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	PDXDC1 GPHN DENND4A SYNE2 LRP2 TRIP11 UVRAG ITPR3	7.91e-07	504	52	8	34432599
Pubmed	Early synapse formation in developing interneurons of the adult olfactory bulb.	GPHN GAD1	2.19e-06	2	52	2	19955355
Pubmed	Functional synergy between cholecystokinin receptors CCKAR and CCKBR in mammalian brain development.	GAD1 LHX8 CXCL12	5.47e-06	23	52	3	25875176
Pubmed	Random walk behavior of migrating cortical interneurons in the marginal zone: time-lapse analysis in flat-mount cortex.	GAD1 CXCL12	6.57e-06	3	52	2	19193877
Pubmed	The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.	SYNE2 OAS2 UTRN	1.24e-05	30	52	3	30480076
Pubmed	Nonclassical MHC Ib-restricted CD8+ T Cells Recognize Mycobacterium tuberculosis-Derived Protein Antigens and Contribute to Protection Against Infection.	HLA-E MR1	1.31e-05	4	52	2	27272249
Pubmed	The CXCL12/CXCR4/ACKR3 Signaling Axis Regulates PKM2 and Glycolysis.	PKM CXCL12	1.31e-05	4	52	2	35681470
Pubmed	SDF1alpha/CXCR4 signaling, via ERKs and the transcription factor Egr1, induces expression of a 67-kDa form of glutamic acid decarboxylase in embryonic hippocampal neurons.	GAD1 CXCL12	1.31e-05	4	52	2	18606818
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	PDS5B BPTF SYNE2 PKM ABCF2 NCBP1 UTRN MYO5C ITPR3	1.89e-05	1024	52	9	24711643
Pubmed	Loss of forebrain cholinergic neurons and impairment in spatial learning and memory in LHX7-deficient mice.	GAD1 LHX8	2.19e-05	5	52	2	15978004
Pubmed	Lysine acetylation targets protein complexes and co-regulates major cellular functions.	DENND4A NCBP1 UVRAG	2.56e-05	38	52	3	19608861
Pubmed	Nesprin-2 is a novel scaffold protein for telethonin and FHL-2 in the cardiomyocyte sarcomere.	MYOM1 SYNE2	3.28e-05	6	52	2	38569934
Pubmed	Identification of independent risk loci for Graves' disease within the MHC in the Japanese population.	HLA-E ITPR3	4.58e-05	7	52	2	21900946
Pubmed	CXCR4 regulates interneuron migration in the developing neocortex.	GAD1 CXCL12	4.58e-05	7	52	2	12832536
Pubmed	Meningeal defects alter the tangential migration of cortical interneurons in Foxc1hith/hith mice.	GAD1 CXCL12	6.10e-05	8	52	2	22248045
Pubmed	Proteomic analysis of exosomes from human neural stem cells by flow field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry.	BPTF SYNE2 RASSF9	7.83e-05	55	52	3	18570454
Pubmed	Genetic mapping of 10 microsatellites in the t complex region of mouse chromosome 17.	HLA-E ITPR3	9.79e-05	10	52	2	9585437
Pubmed	Gene mapping within the T/t complex of the mouse. IV: The inverted MHC is intermingled with several t-lethal genes.	HLA-E ITPR3	9.79e-05	10	52	2	6096010
Pubmed	LIM homeodomain transcription factor-dependent specification of bipotential MGE progenitors into cholinergic and GABAergic striatal interneurons.	GAD1 LHX8	9.79e-05	10	52	2	19855026
Pubmed	CXCR7 Receptor Controls the Maintenance of Subpial Positioning of Cajal-Retzius Cells.	GAD1 CXCL12	1.20e-04	11	52	2	25085881
Pubmed	Polymorphism and linkage of the alpha A-crystallin gene in t-haplotypes of the mouse.	HLA-E ITPR3	1.20e-04	11	52	2	3036643
Pubmed	Mapping of the Pim-1 oncogene in mouse t-haplotypes and its use to define the relative map positions of the tcl loci t0(t6) and tw12 and the marker tf (tufted).	HLA-E ITPR3	1.20e-04	11	52	2	1676981
Pubmed	Mapping to molecular resolution in the T to H-2 region of the mouse genome with a nested set of meiotic recombinants.	HLA-E ITPR3	1.20e-04	11	52	2	2911572
Pubmed	A shared vesicular carrier allows synaptic corelease of GABA and glycine.	GPHN GAD1	1.43e-04	12	52	2	16701208
Pubmed	PAF-AH Catalytic Subunits Modulate the Wnt Pathway in Developing GABAergic Neurons.	GAD1 CXCL12	1.43e-04	12	52	2	20725507
Pubmed	Meiotic mapping of murine chromosome 17: the string of loci around l(17)-2Pas.	HLA-E ITPR3	1.69e-04	13	52	2	1794044
Pubmed	The integrity of cholinergic basal forebrain neurons depends on expression of Nkx2-1.	GAD1 LHX8	1.69e-04	13	52	2	22098391
Pubmed	COUP-TFI mitotically regulates production and migration of dentate granule cells and modulates hippocampal Cxcr4 expression.	GAD1 CXCL12	1.69e-04	13	52	2	28506990
Pubmed	Deficits in microRNA-mediated Cxcr4/Cxcl12 signaling in neurodevelopmental deficits in a 22q11 deletion syndrome mouse model.	GAD1 CXCL12	1.97e-04	14	52	2	24101523
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	BPTF PKM TRIP11 UTRN ITPR3	2.01e-04	360	52	5	33111431
Pubmed	Expression of the Neuronal tRNA n-Tr20 Regulates Synaptic Transmission and Seizure Susceptibility.	GPHN GAD1	2.27e-04	15	52	2	32853550
Pubmed	Three human ARX mutations cause the lissencephaly-like and mental retardation with epilepsy-like pleiotropic phenotypes in mice.	GAD1 LHX8	2.27e-04	15	52	2	19605412
Pubmed	Mapping of 12 markers in the proximal region of mouse chromosome 17 using recombinant t haplotypes.	HLA-E ITPR3	2.27e-04	15	52	2	7749235
Pubmed	New molecular markers for the distal end of the t-complex and their relationships to mutations affecting mouse development.	HLA-E ITPR3	2.27e-04	15	52	2	1350556
Pubmed	Vascular-Derived Vegfa Promotes Cortical Interneuron Migration and Proximity to the Vasculature in the Developing Forebrain.	GAD1 CXCL12	2.27e-04	15	52	2	29901792
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	PDS5B BPTF DENND4A N4BP2 SYNE2 PKM ABCF2 NCBP1 TOP3B	2.60e-04	1442	52	9	35575683
Pubmed	Cloning and characterization of PTP-K1, a novel nonreceptor protein tyrosine phosphatase highly expressed in bone marrow.	PTPRK PTPN18	2.60e-04	16	52	2	8875997
Pubmed	Tbr2-positive intermediate (basal) neuronal progenitors safeguard cerebral cortex expansion by controlling amplification of pallial glutamatergic neurons and attraction of subpallial GABAergic interneurons.	GAD1 CXCL12	2.60e-04	16	52	2	20713522
Pubmed	Psychiatric risk gene Transcription Factor 4 (TCF4) regulates the density and connectivity of distinct inhibitory interneuron subtypes.	GPHN GAD1	2.60e-04	16	52	2	37770578
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	GPHN DENND4A N4BP2 SYNE2 TRIP11 UTRN UVRAG	2.82e-04	861	52	7	36931259
Pubmed	Kv7/KCNQ potassium channels in cortical hyperexcitability and juvenile seizure-related death in Ank2-mutant mice.	GPHN GAD1	3.30e-04	18	52	2	37321992
Pubmed	The LIM homeobox gene, L3/Lhx8, is necessary for proper development of basal forebrain cholinergic neurons.	GAD1 LHX8	3.30e-04	18	52	2	15217369
Pubmed	A role for neural determination genes in specifying the dorsoventral identity of telencephalic neurons.	GAD1 LHX8	3.30e-04	18	52	2	10640277
Pubmed	Cell-Intrinsic Control of Interneuron Migration Drives Cortical Morphogenesis.	GAD1 LHX8	3.69e-04	19	52	2	29474907
Pubmed	Loss of Nkx2.1 homeobox gene function results in a ventral to dorsal molecular respecification within the basal telencephalon: evidence for a transformation of the pallidum into the striatum.	GAD1 LHX8	3.69e-04	19	52	2	10393115
Pubmed	Robo1 regulates semaphorin signaling to guide the migration of cortical interneurons through the ventral forebrain.	GAD1 LHX8	3.69e-04	19	52	2	21508241
Pubmed	SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity.	GAD1 NWD2 STON1 ING1 MR1 ATP8B1 CXCL12	4.07e-04	915	52	7	32393512
Pubmed	Inactivation of Arx, the murine ortholog of the X-linked lissencephaly with ambiguous genitalia gene, leads to severe disorganization of the ventral telencephalon with impaired neuronal migration and differentiation.	GAD1 LHX8	4.09e-04	20	52	2	17460091
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	PDS5B BPTF SYNE2 NCBP1 UTRN ITPR3	4.19e-04	653	52	6	22586326
Pubmed	The microcephaly gene Donson is essential for progenitors of cortical glutamatergic and GABAergic neurons.	GAD1 CXCL12	4.52e-04	21	52	2	33739968
Pubmed	Zic deficiency in the cortical marginal zone and meninges results in cortical lamination defects resembling those in type II lissencephaly.	GAD1 CXCL12	4.97e-04	22	52	2	18448648
Pubmed	Different timings of Dicer deletion affect neurogenesis and gliogenesis in the developing mouse central nervous system.	GAD1 LHX8	5.44e-04	23	52	2	19806666
Pubmed	FGF signalling generates ventral telencephalic cells independently of SHH.	GAD1 LHX8	5.44e-04	23	52	2	16818446
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	PDXDC1 GPHN PTPRK ABCF2 PTPN18 UTRN ITPR3	5.90e-04	974	52	7	28675297
Pubmed	Release of calcium from inositol 1,4,5-trisphosphate receptor-regulated stores by HIV-1 Tat regulates TNF-alpha production in human macrophages.	PRKD1 ITPR3	5.93e-04	24	52	2	10843712
Pubmed	Olig1 function is required to repress dlx1/2 and interneuron production in Mammalian brain.	GPHN GAD1	6.96e-04	26	52	2	24507192
Pubmed	Gamma protocadherins are required for survival of spinal interneurons.	GPHN GAD1	6.96e-04	26	52	2	12467588
Pubmed	ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.	PKM ABCF2 UTRN MYO5C	6.98e-04	268	52	4	33024031
Pubmed	Genome-wide association study of hematological and biochemical traits in a Japanese population.	MED24 DENND4A LRP2	7.09e-04	116	52	3	20139978
Pubmed	Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef.	HLA-E CXCL12	7.51e-04	27	52	2	22844345
Pubmed	Phrenic-specific transcriptional programs shape respiratory motor output.	GPHN GAD1	7.51e-04	27	52	2	31944180
Pubmed	Full function of exon junction complex factor, Rbm8a, is critical for interneuron development.	GPHN GAD1	8.08e-04	28	52	2	33154347
Pubmed	Lhx6 and Lhx8 coordinately induce neuronal expression of Shh that controls the generation of interneuron progenitors.	GAD1 LHX8	8.08e-04	28	52	2	21658586
Pubmed	Dlx5 and Dlx6 regulate the development of parvalbumin-expressing cortical interneurons.	GAD1 CXCL12	8.08e-04	28	52	2	20392955
Pubmed	Atm deficiency in the DNA polymerase β null cerebellum results in cerebellar ataxia and Itpr1 reduction associated with alteration of cytosine methylation.	GAD1 ITPR3	8.67e-04	29	52	2	32123907
Pubmed	SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron.	GAD1 LHX8	8.67e-04	29	52	2	17928865
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PTPRK SYNE2 NCBP1 PTPN18 UTRN TOP3B ITPR3	9.12e-04	1049	52	7	27880917
Pubmed	Conversion of cerebral cortex into basal ganglia in Emx2(-/-) Pax6(Sey/Sey) double-mutant mice.	GAD1 LHX8	9.29e-04	30	52	2	12118260
Pubmed	Dlx1&2-dependent expression of Zfhx1b (Sip1, Zeb2) regulates the fate switch between cortical and striatal interneurons.	GAD1 LHX8	9.92e-04	31	52	2	23312518
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	PDXDC1 TDRD15 STON1 PKM FMNL2 TRIP11	1.04e-03	777	52	6	35844135
Pubmed	The progenitor zone of the ventral medial ganglionic eminence requires Nkx2-1 to generate most of the globus pallidus but few neocortical interneurons.	GAD1 LHX8	1.19e-03	34	52	2	20181579
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	PDXDC1 NCBP1 FMNL2 UTRN	1.24e-03	313	52	4	38270169
Pubmed	Development of an efficient screening system to identify novel bone metabolism-related genes using the exchangeable gene trap mutagenesis mouse models.	BPTF APOBEC1	1.26e-03	35	52	2	28106071
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	PDXDC1 GPHN PTPRK HLA-E PKM OAS2 ABCF2 TRIP11	1.32e-03	1451	52	8	30550785
Pubmed	Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex.	GPHN SYNE2	1.41e-03	37	52	2	27565344
Pubmed	Identification of UHRF1/2 as new N-methylpurine DNA glycosylase-interacting proteins.	PKM NCBP1	1.49e-03	38	52	2	23537643
Cytoband	4p14	NWD2 N4BP2	1.09e-03	42	53	2	4p14
Cytoband	Ensembl 112 genes in cytogenetic band chr4p14	NWD2 N4BP2	2.76e-03	67	53	2	chr4p14
GeneFamily	C1-set domain containing	HLA-E MR1	2.50e-03	42	32	2	591
GeneFamily	PHD finger proteins	BPTF ING1	1.10e-02	90	32	2	88
Coexpression	GENTILE_UV_LOW_DOSE_DN	PTPRK MYO10 UTRN CXCL12	8.65e-06	64	53	4	M4594
Coexpression	LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3	PTPRK SYNE2 HLA-E LRP2 FMNL2	3.26e-05	181	53	5	M39225
Coexpression	GSE39556_CD8A_DC_VS_NK_CELL_DN	DENND4A GUCY2C OAS2 PTPN18 UVRAG	5.00e-05	198	53	5	M9407
Coexpression	GSE24726_WT_VS_E2_2_KO_PDC_DN	ING1 PKM ABCF2 NCBP1 TRAPPC6A	5.24e-05	200	53	5	M8061
Coexpression	GSE24210_RESTING_TREG_VS_TCONV_UP	ING1 N4BP2 SYNE2 PTPN18 ITPR3	5.24e-05	200	53	5	M7839
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	GPHN PTPRK LRP2 PRKD1 MYO5C ITPR3	1.09e-07	192	53	6	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	GPHN BTBD16 PTPRK LRP2 PRKD1 MYO5C	1.09e-07	192	53	6	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GPHN PDS5B ATP8B1 UTRN CXCL12	2.45e-06	181	53	5	136b0c60680068838d184d32aa99d7bea8718dbc
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRK SYNE2 AGMO LRP2 FMNL2	2.80e-06	186	53	5	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	BPTF PTPRK N4BP2 TRIP11 UTRN	3.35e-06	193	53	5	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	GPHN PTPRK LRP2 PRKD1 ITPR3	3.35e-06	193	53	5	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	BPTF SYNE2 PTPN18 TRIP11 UTRN	3.79e-06	198	53	5	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	BPTF STON1 SYNE2 PTPN18 TRIP11	3.89e-06	199	53	5	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	BPTF SYNE2 PTPN18 TRIP11 UTRN	3.89e-06	199	53	5	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	BPTF SYNE2 HLA-E OAS2 UTRN	3.98e-06	200	53	5	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	BPTF SYNE2 PTPN18 TRIP11	2.21e-05	138	53	4	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	E16.5-samps-Myeloid-Macrophage\|E16.5-samps / Age Group, Lineage, Cell class and subclass	OAS2 APOBEC1 DNAAF11 TMEM106A	2.90e-05	148	53	4	cd5f697d8c2f272be1f3f52a05446749278431c5
ToppCell	E16.5-samps-Myeloid-Macrophage-CD163+_Macrophage\|E16.5-samps / Age Group, Lineage, Cell class and subclass	OAS2 APOBEC1 DNAAF11 TMEM106A	2.90e-05	148	53	4	56e146980a71b5ca655118ae13310c5949220d4a
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	PDXDC1 DENND4A SYNE2 NOCT	3.57e-05	156	53	4	1545169694f686d28648a68b552c2ae606599d66
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	OAS2 APOBEC1 PTPN18 TMEM106A	4.44e-05	165	53	4	cece16b03282d27fb49102eb9c104a2024efd28c
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNE2 ATP8B1 UTRN CXCL12	4.55e-05	166	53	4	7a45785a40b7425f97be67bab1c5ceb69b2bd85a
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNE2 ATP8B1 UTRN CXCL12	4.55e-05	166	53	4	bbd382812f8a84a5d99888de2d7cca3a8b5e4695
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	OAS2 APOBEC1 PTPN18 TMEM106A	4.99e-05	170	53	4	6ec0cf055ae55e9fac147f7989c47f83ab07270c
ToppCell	PND07-28-samps-Myeloid-Macrophage-CD163+_Macrophage\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	OAS2 APOBEC1 PTPN18 TMEM106A	5.22e-05	172	53	4	9a659442dc41bd2a4361a7e38a7ee37a39781667
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_4\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	PTPRK MYO10 AGMO ATP8B1	5.46e-05	174	53	4	110369f6b78de34a6d934b5b47cecd023347bc80
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 SYNE2 UTRN CXCL12	5.83e-05	177	53	4	ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 SYNE2 UTRN CXCL12	5.83e-05	177	53	4	f471f7747d6e8db7546899019af9508f48a14f89
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 SYNE2 UTRN CXCL12	5.83e-05	177	53	4	cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 SYNE2 TRIP11 UTRN	5.96e-05	178	53	4	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	BAL-Mild-cDC_4\|Mild / Compartment, Disease Groups and Clusters	MYOM1 SYNE2 MR1 ITPR3	6.09e-05	179	53	4	68511e87b12b8253de7771e5ccfc5869248b8450
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	GPHN PTPRK LRP2 PRKD1	6.23e-05	180	53	4	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 SYNE2 RASSF9 UTRN	6.36e-05	181	53	4	92d44892bb15771f0ab5fe61879b204b0acbd9b3
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ROPN1L HLA-E OAS2 RASSF9	6.50e-05	182	53	4	8d8f28bd43108b2fb3a6c2a3d77a897853d440a4
ToppCell	droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 SYNE2 RASSF9 UTRN	6.50e-05	182	53	4	81279877b920b5a1bc991a07d3031d6458700fe3
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATP8B1 UTRN CXCL12 ITPR3	6.64e-05	183	53	4	3427f3cbe6ea81709750e7dd3ff378f03ae65eab
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	GPHN MED24 MR1 NCBP1	6.64e-05	183	53	4	310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	BTBD16 PTPRK LRP2 PRKD1	6.64e-05	183	53	4	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	GPHN MED24 MR1 NCBP1	6.64e-05	183	53	4	fef51dcf180e6d4e136362c7e140ec5ef372e6d0
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SYNE2 RASSF9 UTRN MYO5C	6.78e-05	184	53	4	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RMND5A STON1 MYOM1 MR1	6.92e-05	185	53	4	aa2c36e2cce0f0a536cd1dfc3788b6fee6f21b6b
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STON1 MYO10 SYNE2 UTRN	7.07e-05	186	53	4	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	STON1 PRKD1 RASSF9 CXCL12	7.22e-05	187	53	4	f1d0fc625e0e7881b3f290742fd7148d995eb71e
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	STON1 PRKD1 RASSF9 CXCL12	7.22e-05	187	53	4	02e7246ef5ad41773d14426254e139b156d45c1d
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO10 HLA-E UTRN MYO5C	7.22e-05	187	53	4	0ef82111b9049cc7ee78d64d240e1f10ab14d6b6
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	STON1 PRKD1 RASSF9 CXCL12	7.22e-05	187	53	4	08c73d125e0638c9e9878165bba2442c266c8a48
ToppCell	P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ATP8B1 UTRN CXCL12 ITPR3	7.22e-05	187	53	4	66ebe1788d51b3e17bec6cdb219f709756b4e530
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	DENND4A SYNE2 NOCT UTRN	7.37e-05	188	53	4	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NWD2 PTPRK SLC22A10 MYO5C	7.37e-05	188	53	4	50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D231\|Adult / Lineage, Cell type, age group and donor	PTPRK LRP2 PRKD1 ITPR3	7.52e-05	189	53	4	dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LRP2 ATP8B1 RASSF9 MYO5C	7.83e-05	191	53	4	60ff989fe99d243a3d52955223680cdd1f1917a4
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GPHN PTPRK PRKD1 MYO5C	7.83e-05	191	53	4	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	facs-Thymus-Epithelium-3m-Endothelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 ATP8B1 RASSF9 CXCL12	7.83e-05	191	53	4	6676ef9aeb890668cb69e67865404061b8467c25
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATP8B1 RASSF9 UTRN CXCL12	7.83e-05	191	53	4	b270c3dd5952f56b9bdceabe13e298fe6757563b
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATP8B1 RASSF9 UTRN CXCL12	7.83e-05	191	53	4	27f23c2254b610abac1a88d0fecff305addde9da
ToppCell	facs-Thymus-Epithelium-3m-Endothelial-endothelial_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 ATP8B1 RASSF9 CXCL12	7.83e-05	191	53	4	a157cee0fbc9dce64308128c3578e7327fa178b7
ToppCell	facs-Thymus-Epithelium-3m-Endothelial-endothelial_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 ATP8B1 RASSF9 CXCL12	7.83e-05	191	53	4	d2311a5b0cf186839000f9f272b6fbc2270ddb44
ToppCell	P07-Endothelial-large_vessel_endothelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ATP8B1 RASSF9 UTRN CXCL12	7.83e-05	191	53	4	d162917816dd2e4767c97447c1cddae9397713ab
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	BPTF PTPRK PRKD1 UTRN	7.99e-05	192	53	4	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATP8B1 UTRN CXCL12 ITPR3	7.99e-05	192	53	4	285a9d332a1e07b94f222d4b518dd56928b9e075
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	MYO10 SYNE2 HLA-E UTRN	7.99e-05	192	53	4	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	GPHN PTPRK SYNE2 LRP2	7.99e-05	192	53	4	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GPHN PTPRK LRP2 PRKD1	8.15e-05	193	53	4	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GPHN DENND4A FMNL2 UTRN	8.15e-05	193	53	4	779276e775cb2492e8dd36436295a536084a6415
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GPHN PTPRK LRP2 PRKD1	8.15e-05	193	53	4	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	RV-09._Endothelium_I\|RV / Chamber and Cluster_Paper	SYNE2 HLA-E PRKD1 UTRN	8.32e-05	194	53	4	7b408096e717f2327c12aea35a8d5fc4621d3b06
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GPHN PTPRK SYNE2 LRP2	8.32e-05	194	53	4	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GPHN BTBD16 PTPRK PRKD1	8.32e-05	194	53	4	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GAD1 PKM PRKD1 CXCL12	8.49e-05	195	53	4	3123e02d2894c83962ba402085b5e6422ebf8c73
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	MYO10 SYNE2 HLA-E UTRN	8.49e-05	195	53	4	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	(1)_T_cells-(1)_T_CD4_naive\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	BPTF N4BP2 PTPN18 TRIP11	8.49e-05	195	53	4	d3fa551bc6f5ee5890af1040415e61ecd5d46201
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAD1 MYO10 PKM TRIP11	8.49e-05	195	53	4	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PTPRK LRP2 PRKD1 MYO5C	9.00e-05	198	53	4	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	CV-Mild-1\|CV / Virus stimulation, Condition and Cluster	SYNE2 HLA-E OAS2 UTRN	9.00e-05	198	53	4	4b078714c49e7befb7b113d72485e712236d35fa
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	BPTF SYNE2 PTPN18 TRIP11	9.18e-05	199	53	4	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	BPTF SYNE2 PTPN18 TRIP11	9.18e-05	199	53	4	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	BPTF SYNE2 PTPN18 TRIP11	9.18e-05	199	53	4	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-E ATP8B1 UTRN CXCL12	9.18e-05	199	53	4	9b02acae6325b0ac9642438a4431285ff396e5fe
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	BPTF SYNE2 PTPN18 TRIP11	9.18e-05	199	53	4	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	Control-NK\|Control / Disease condition and Cell class	SYNE2 HLA-E PTPN18 UTRN	9.18e-05	199	53	4	f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	BPTF SYNE2 PTPN18 TRIP11	9.18e-05	199	53	4	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	BPTF SYNE2 PTPN18 TRIP11	9.18e-05	199	53	4	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial\|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X	MED24 SYNE2 HLA-E CXCL12	9.36e-05	200	53	4	2ae62c428728c1d9d4471d4be24bd6ab074fa22c
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BPTF SYNE2 OAS2 UTRN	9.36e-05	200	53	4	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	BPTF SYNE2 OAS2 UTRN	9.36e-05	200	53	4	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Mild / Disease, condition lineage and cell class	SYNE2 HLA-E OAS2 ABCF2	9.36e-05	200	53	4	d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW09-Stem_cells-Stem_cells\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	MYO10 SYNE2 PKM UTRN	9.36e-05	200	53	4	c00cc0b91baa37828895d9d6b8acbc6aa503215a
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW09-Stem_cells\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	MYO10 SYNE2 PKM UTRN	9.36e-05	200	53	4	9e1b62a703fb7d413ce580448a1df5127c28e8a7
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	SYNE2 HLA-E OAS2 UTRN	9.36e-05	200	53	4	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_B1\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	BTBD16 STON1 RASSF9	4.03e-04	121	53	3	4765e6ec00b0cf10d08cbd738c68a51d21bfb625
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_B1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	BTBD16 STON1 RASSF9	4.54e-04	126	53	3	10e1448a03f79965b72922fd83ef51de1b7b474f
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9\|TCGA-Bladder / Sample_Type by Project: Shred V9	PTPRK PKM TRIP11	5.19e-04	132	53	3	48449e2e95804a26f204ac7ea763dee26cf794ab
ToppCell	Fetal_29-31_weeks-Immune-mast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TDRD15 SLC22A10 TMEM106A	5.43e-04	134	53	3	1d6e74612fd91a2ef9d14bf77262b2d08e1052ca
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MED24 ROPN1L MR1	5.79e-04	137	53	3	e9b88ad86b75454a8292a94879c5b665adc42744
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SYNE2 HLA-E FMNL2	6.04e-04	139	53	3	2fdc8f36510aff24abbc79ef2a842db75a85f946
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SYNE2 HLA-E FMNL2	6.04e-04	139	53	3	5970a654c64e3b54f9d18c102f5b125eec892fc5
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	OAS2 APOBEC1 TMEM106A	6.42e-04	142	53	3	be63c48794a227ea55978524c0f5935342fc455e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TDRD15 MYO10 LRP2	7.68e-04	151	53	3	f4f7156b2c0cfc78fd1841e07c9915d97ced561f
ToppCell	MS-CD4-antiviral_CD4\|MS / Condition, Cell_class and T cell subcluster	SYNE2 HLA-E OAS2	7.82e-04	152	53	3	b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee
ToppCell	facs-Marrow-KLS-18m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRK LHX8 CXCL12	8.13e-04	154	53	3	37765512dfae557b9f6eb30a29463b93682a4404
ToppCell	CV-Healthy-3\|Healthy / Virus stimulation, Condition and Cluster	DENND4A HLA-E ATP8B1	8.13e-04	154	53	3	26bf81a86700db7e65c2384ffe94ed4253ea4047
ToppCell	10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3\|bone_marrow / Manually curated celltypes from each tissue	AXDND1 LRP2 PRKD1	8.28e-04	155	53	3	83430a64c2cb5ad29caa3dacba76c28dd204ac40
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NWD2 PTPRK CXCL12	8.43e-04	156	53	3	09e0702400570089d9012dcf94dfb4827c97e49d
ToppCell	Myeloid-A_(Macrophage-Dendritic)\|World / shred on cell class and cell subclass (v4)	PKM APOBEC1 PTPN18	8.43e-04	156	53	3	08d5f7fe098b6f2caeeddcc5ed1e34d6a59e697b
ToppCell	PBMC-Control-cDC_1\|Control / Compartment, Disease Groups and Clusters	ROPN1L OAS2 TMEM106A	8.43e-04	156	53	3	9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3\|TCGA-Skin / Sample_Type by Project: Shred V9	STON1 MYO10 FMNL2	8.91e-04	159	53	3	fb222c42f66901852b01cec073ec0732245ee973
Drug	Lincomycin	HLA-E MR1	5.32e-06	2	53	2	ctd:D008034
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A	RMND5A MR1 ATP8B1 NOCT PTPN18 UTRN	6.36e-06	197	53	6	3727_DN
Drug	Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; PC3; HT_HG-U133A	GAD1 RMND5A LRP2 DNAAF11 PTPN18 CXCL12	6.36e-06	197	53	6	5735_DN
Drug	Naloxone hydrochloride [357-08-4]; Down 200; 11uM; MCF7; HT_HG-U133A	DENND4A ING1 MYO10 OAS2 TRIP11 ITPR3	6.55e-06	198	53	6	1506_DN
Drug	3-methyl-2-nitrophenol	GBA3 PKM	3.18e-05	4	53	2	CID000021026
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	PDS5B BPTF MYO10 UVRAG CXCL12	6.67e-05	183	53	5	7498_DN
Drug	Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	GPHN PDS5B ING1 UTRN CXCL12	6.67e-05	183	53	5	5613_DN
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	RMND5A MYO10 MR1 OAS2 UTRN	7.77e-05	189	53	5	1646_UP
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A	RMND5A ING1 OAS2 NOCT PTPN18	8.36e-05	192	53	5	5206_DN
Drug	Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A	STON1 OAS2 ABCF2 NOCT PTPN18	8.78e-05	194	53	5	3169_DN
Drug	Tolnaftate [2398-96-1]; Down 200; 13uM; PC3; HT_HG-U133A	MYO10 MR1 NCBP1 DNAAF11 PTPN18	8.78e-05	194	53	5	4221_DN
Drug	Spiramycin [8025-81-8]; Down 200; 4.8uM; MCF7; HT_HG-U133A	RMND5A OAS2 PTPN18 TRIP11 UTRN	8.78e-05	194	53	5	3938_DN
Drug	0179445-0000 [211246-22-9]; Down 200; 1uM; MCF7; HT_HG-U133A	GAD1 ING1 ABCF2 NOCT TRIP11	8.78e-05	194	53	5	4758_DN
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A	RMND5A ABCF2 PRKD1 DNAAF11 UTRN	8.78e-05	194	53	5	3725_DN
Drug	Piromidic acid [19562-30-2]; Up 200; 13.8uM; MCF7; HT_HG-U133A	GAD1 RMND5A ING1 ABCF2 ITPR3	9.00e-05	195	53	5	3335_UP
Drug	Diethylstilbestrol [56-53-1]; Down 200; 15uM; PC3; HT_HG-U133A	DENND4A ING1 PTPN18 UTRN TOP3B	9.00e-05	195	53	5	3812_DN
Drug	Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A	GAD1 DENND4A STON1 ATP8B1 NOCT	9.00e-05	195	53	5	6648_DN
Drug	Lactobionic acid [96-82-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A	RMND5A STON1 MR1 TRIP11 UTRN	9.00e-05	195	53	5	3246_UP
Drug	Harmane hydrochloride [21655-84-5]; Down 200; 18.2uM; MCF7; HT_HG-U133A	PDS5B GAD1 ING1 MR1 OAS2	9.22e-05	196	53	5	4408_DN
Drug	Nicergoline; Down 200; 8.2uM; PC3; HT_HG-U133A	ING1 MR1 ABCF2 PTPN18 TRAPPC6A	9.22e-05	196	53	5	2058_DN
Drug	Isosorbide dinitrate [87-33-2]; Down 200; 17uM; MCF7; HT_HG-U133A	ING1 ABCF2 NOCT UTRN TOP3B	9.22e-05	196	53	5	6038_DN
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A	PDS5B ING1 MR1 ABCF2 UTRN	9.44e-05	197	53	5	2128_DN
Drug	Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; HL60; HT_HG-U133A	ING1 LRP2 OAS2 ABCF2 DNAAF11	9.44e-05	197	53	5	3127_DN
Drug	Dichlorphenamide [120-97-8]; Down 200; 13.2uM; PC3; HT_HG-U133A	GAD1 DENND4A NCBP1 DNAAF11 PTPN18	9.44e-05	197	53	5	6686_DN
Drug	Capsaicin [404-86-4]; Down 200; 13uM; MCF7; HT_HG-U133A	ING1 ABCF2 NCBP1 UTRN TOP3B	9.44e-05	197	53	5	3372_DN
Drug	Cinchonine [118-10-5]; Up 200; 13.6uM; PC3; HT_HG-U133A	STON1 NCBP1 APOBEC1 TOP3B ITPR3	9.44e-05	197	53	5	3988_UP
Drug	Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	RMND5A ING1 MR1 PTPN18 TRIP11	9.44e-05	197	53	5	3894_DN
Drug	Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; HL60; HT_HG-U133A	LRP2 MR1 OAS2 APOBEC1 DNAAF11	9.67e-05	198	53	5	2905_UP
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; PC3; HT_HG-U133A	GAD1 OAS2 DNAAF11 PTPN18 CXCL12	9.67e-05	198	53	5	4546_DN
Drug	Triamterene [396-01-0]; Down 200; 15.8uM; PC3; HT_HG-U133A	PDS5B RMND5A ING1 ABCF2 PTPN18	9.67e-05	198	53	5	7307_DN
Drug	Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A	GAD1 MR1 DNAAF11 TRIP11 UTRN	9.67e-05	198	53	5	4956_UP
Drug	Pyrazinamide [ 98-96-4]; Down 200; 32.4uM; PC3; HT_HG-U133A	STON1 ING1 ABCF2 UTRN TRAPPC6A	9.90e-05	199	53	5	6617_DN
Drug	Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; HL60; HG-U133A	MR1 ABCF2 NOCT PTPN18 TOP3B	9.90e-05	199	53	5	1725_UP
Drug	Iobenguane sulfate; Down 200; 10.8uM; MCF7; HT_HG-U133A	DENND4A RMND5A MYO10 MR1 ABCF2	9.90e-05	199	53	5	6002_DN
Drug	Ramipril [87333-19-5]; Down 200; 9.6uM; HL60; HT_HG-U133A	ING1 OAS2 ABCF2 TRIP11 UTRN	1.01e-04	200	53	5	6150_DN
Drug	Ascorbic acid [50-81-7]; Down 200; 22.4uM; HL60; HG-U133A	MED24 LRRC42 RMND5A ATP8B1 NOCT	1.01e-04	200	53	5	1610_DN
Drug	GBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A	STON1 LRP2 OAS2 NCBP1 TRIP11	1.01e-04	200	53	5	3240_DN
Drug	Vitexin [3681-93-4]; Up 200; 9.2uM; PC3; HT_HG-U133A	MR1 ABCF2 NCBP1 UTRN ITPR3	1.01e-04	200	53	5	4588_UP
Disease	waist circumference	PDXDC1 BPTF PTPRK N4BP2 SYNE2 PRKD1	1.05e-04	429	52	6	EFO_0004342
Disease	triglycerides in LDL measurement	TDRD15 BPTF SYNE2	1.34e-04	56	52	3	EFO_0022320
Disease	metabolite measurement	PDXDC1 GBA3 BPTF SYNE2 NCBP1 UVRAG	4.42e-04	560	52	6	EFO_0004725
Disease	age at first sexual intercourse measurement	PDXDC1 BPTF PRKD1 LHX8 UTRN	5.65e-04	383	52	5	EFO_0009749
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	PDXDC1 TDRD15 BPTF SYNE2	6.58e-04	224	52	4	EFO_0004530, EFO_0008317
Disease	memory performance	PDS5B DENND4A N4BP2 SYNE2 PRKD1	7.60e-04	409	52	5	EFO_0004874
Disease	fatty acid measurement	PDXDC1 TDRD15 BPTF MYO10 UVRAG	1.01e-03	436	52	5	EFO_0005110
Disease	cholesterol to total lipids in medium LDL percentage	PDXDC1 TDRD15	1.04e-03	27	52	2	EFO_0022238
Disease	unipolar depression	GPHN BPTF MYO10 SYNE2 AGMO HLA-E NOCT TRIP11	1.16e-03	1206	52	8	EFO_0003761
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	PDXDC1 TDRD15 SYNE2	1.28e-03	121	52	3	EFO_0008595, EFO_0020943
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	PDXDC1 TDRD15 BPTF UVRAG	1.39e-03	274	52	4	EFO_0004530, EFO_0004612
Disease	phosphatidylcholine measurement	PDXDC1 TDRD15 SYNE2 UVRAG	1.58e-03	284	52	4	EFO_0010226
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	PDXDC1 TDRD15 BPTF SYNE2	1.73e-03	291	52	4	EFO_0008317, EFO_0020946
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	PDXDC1 TDRD15 SYNE2	2.11e-03	144	52	3	EFO_0004611, EFO_0020943
Disease	lysophosphatidylcholine 20:3 measurement	PDXDC1 PRKD1	2.28e-03	40	52	2	EFO_0010362
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	PDXDC1 TDRD15 SYNE2	2.37e-03	150	52	3	EFO_0004611, EFO_0020947
Disease	fibroblast growth factor 23 measurement	PDS5B RASSF9	2.63e-03	43	52	2	EFO_0009381
Disease	triglycerides in large LDL measurement	TDRD15 SYNE2	2.63e-03	43	52	2	EFO_0022319
Disease	retinal nerve fibre layer thickness measurement	PDXDC1 STON1	2.63e-03	43	52	2	EFO_0600004
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	GBA3 BPTF PTPRK NOCT LHX8 UTRN	2.76e-03	801	52	6	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	TDRD15 BPTF SYNE2	3.16e-03	166	52	3	EFO_0004530, EFO_0004611
Disease	schizophrenia, intelligence, self reported educational attainment	PDXDC1 GBA3 DENND4A PRKD1	3.23e-03	346	52	4	EFO_0004337, EFO_0004784, MONDO_0005090

Protein segments in the cluster

Peptide	Gene	Start	Entry
LFCITLIKEKWLNED	PTPN18	156	Q99952
LDACVWLEEELKTFK	ABCF2	261	Q9UG63
ELRKEACLLYEIKWG	APOBEC1	31	P41238
YKEEQLTTGCEKWLE	BTBD16	221	Q32M84
CIDKNYAGVLIIWDK	AGMO	231	Q6ZNB7
CLDKDYWEAELCKIL	BPTF	506	Q12830
LCYKEIEEKEFTEWN	ATP8B1	656	O43520
KLETKLLEEWYCRDE	NWD2	151	Q9ULI1
LYDWKERLKQGCEII	DENND4A	106	Q7Z401
EKEIVVWVCQEEKLV	RASSF9	26	O75901
IEQLKDVKECLWFVL	PDS5B	1011	Q9NTI5
KELEVYLLVKNCWEE	GUCY2C	716	P25092
IKETLIDWCDEKELN	GPHN	66	Q9NQX3
WDYKNIIEKLQDIIT	ITPR3	1586	Q14573
LEDTCVEWLHKYLEK	HLA-E	181	P13747
DYQTWLDLRELECKI	PRKD1	841	Q15139
EEYLDCLWAQIQKLK	NCBP1	226	Q09161
IQEIADICEKYNLWL	GAD1	356	Q99259
LKELCEQYGIWLHVE	PDXDC1	256	Q6P996
LKELCEQYGIWLHVE	PDXDC2P	256	Q6P474
WIDNGECLDLIEKKL	MYO10	486	Q9HD67
ILWLDYKNICKVVEV	PKM	156	P14618
EIVDKYLLKVNDLCW	LHX8	81	Q68G74
KQKYVCLAVEDWDLL	LRRC42	411	Q9Y546
LECVTLDIEEQKLYW	LRP2	1921	P98164
VLELIKCQEKLCIYW	OAS2	251	P29728
YTLWEEDLKCIKQLG	GBA3	56	Q9H227
EVDKLKKECYEWINT	AXDND1	791	Q5T1B0
KKYSDCAWEIVRVEI	IFNK	176	Q9P0W0
LEHIDKWCRDLKILY	DNAAF11	36	Q86X45
LLRQYDNEKKWELIC	FMNL2	51	Q96PY5
KWEERKCLILEEILA	NOCT	171	Q9UK39
FLKLILQVEKWQEEC	PTPRK	1351	Q15262
ELLYQKNWLEEECIA	MR1	171	Q95460
DENTYKICTWLEIKV	TMEM106A	201	Q96A25
EEQCLLKAWLTEKEE	UTRN	536	P46939
KENIYQLLIEWKVCL	UVRAG	121	Q9P2Y5
DELPIEVDLGKKCWY	RMND5A	316	Q9H871
EKFLYCCEKWIQLLE	SYNE2	5596	Q8WXH0
CCEKWIQLLEKIEEA	SYNE2	5601	Q8WXH0
ICDEKCVINELLKWK	TDRD15	1456	B5MCY1
IVTKWDLVCDYQSLK	SLC22A10	131	Q63ZE4
PWKQILKELDECYER	ING1	186	Q9UK53
VYWFCNNLIKELLKE	MED24	741	O75448
YIVLWLDCDKEGENI	TOP3B	111	O95985
ACYNIQVEIEKKWIK	STON1	706	Q9Y6Q2
YVELTDLEQKWKNLC	ROPN1L	91	Q96C74
CCEKWELVEKVNRLY	RNF34	286	Q969K3
EELDVLKFLCKDLWV	TRAPPC6A	61	O75865
IEAELCWAKKRLLEE	TRIP11	721	Q15643
CIDPKLKWIQEYLEK	CXCL12	71	P48061
IRCNISYLEEWLKDK	MYO5C	1606	Q9NQX4
ALKDLYERCNKDIIW	N4BP2	1106	Q86UW6
VKCLEANKDYIIISW	MYOM1	516	P52179